FP Analytics

FP Analytics is the independent research and advisory division of the FP Group (Foreign Policy), specializing in providing data-driven analysis and strategic intelligence on global policy, markets, and technology. The firm maintains a significant focus on the biopharmaceutical and healthcare sectors, where it is widely recognized for producing the Biopharmaceutical Competitiveness and Investment (BCI) Index, a key benchmark for evaluating national innovation ecosystems. FP Analytics leads high-level simulations and produces in-depth research on critical global health challenges, including antimicrobial resistance (AMR), pandemic preparedness, and non-communicable diseases. The organization frequently collaborates with major pharmaceutical companies, industry associations such as the IFPMA, and international health organizations to inform strategic planning and policy-shaping discussions.